We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$41B
AUM Growth
-$3.23B
(-7.3%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
14.31%
Holding
2,407
New
233
Increased
1,091
Reduced
839
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$119M |
| 2 |
Valero Energy
VLO
|
+$117M |
| 3 |
Chevron
CVX
|
+$89.6M |
| 4 |
Booking.com
BKNG
|
+$88.5M |
| 5 |
Mastercard
MA
|
+$85.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allstate
ALL
|
+$109M |
| 2 |
Moderna
MRNA
|
+$105M |
| 3 |
Goldman Sachs
GS
|
+$97.9M |
| 4 |
Lennar Class A
LEN
|
+$81M |
| 5 |
Emerson Electric
EMR
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.89% |
| 2 | Healthcare | 15.51% |
| 3 | Financials | 11.51% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Industrials | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Protolabs
PRLB
$2.21B
| $1.99M | ﹤0.01% |
54,648
+32,191
| +143% | +$1.4M |
|
1202
Chegg
CHGG
$89.3M
| $1.99M | ﹤0.01% |
94,300
-268,249
| -74% | -$5.56M |
|
|
HBI
1203
DELISTED
Hanesbrands
HBI
| $1.99M | ﹤0.01% |
285,383
-146,915
| -34% | -$1.44M |
|
1204
TriNet
TNET
$3.22B
| $1.99M | ﹤0.01% |
27,874
+14,546
| +109% | +$1.18M |
|
1205
Varex Imaging
VREX
$780M
| $1.98M | ﹤0.01% |
93,546
+27,792
| +42% | +$608K |
|
1206
Cytokinetics
CYTK
$10.2B
| $1.98M | ﹤0.01% |
40,812
+2,637
| +7% | +$127K |
|
1207
Apogee Enterprises
APOG
$888M
| $1.97M | ﹤0.01% |
51,490
+20,702
| +67% | +$844K |
|
1208
Martin Marietta Materials
MLM
$32.7B
| $1.97M | ﹤0.01% |
6,124
-6,719
| -52% | -$2.27M |
|
1209
Amneal Pharmaceuticals
AMRX
$6.02B
| $1.96M | ﹤0.01% |
972,161
+679,824
| +233% | +$1.91M |
|
|
ECHO
1210
EchoStar
ECHO
$26.6B
| $1.96M | ﹤0.01% |
119,258
+90,789
| +319% | +$1.7M |
|
1211
Tilly's
TLYS
$122M
| $1.96M | ﹤0.01% |
283,855
+64,987
| +30% | +$493K |
|
1212
Trade Desk
TTD
$6.84B
| $1.96M | ﹤0.01% |
32,828
-25,011
| -43% | -$1.42M |
|
|
CIO
1213
DELISTED
City Office REIT
CIO
| $1.96M | ﹤0.01% |
196,454
+95,171
| +94% | +$1.17M |
|
1214
Piper Sandler
PIPR
$5.54B
| $1.95M | ﹤0.01% |
74,624
+3,084
| +4% | +$89.8K |
|
1215
Insteel Industries
IIIN
$634M
| $1.95M | ﹤0.01% |
73,351
+2,881
| +4% | +$89.3K |
|
|
EXPR
1216
DELISTED
Express, Inc.
EXPR
| $1.94M | ﹤0.01% |
88,784
+87,543
| +7,054% | +$2.99M |
|
1217
International Money Express
IMXI
$353M
| $1.93M | ﹤0.01% |
84,878
-37,253
| -31% | -$876K |
|
1218
Atara Biotherapeutics
ATRA
$76.7M
| $1.93M | ﹤0.01% |
+20,407
| New | +$2.29M |
|
1219
SITE Centers
SITC
$158M
| $1.93M | ﹤0.01% |
230,322
+77,427
| +51% | +$810K |
|
1220
QCR Holdings
QCRH
$1.75B
| $1.92M | ﹤0.01% |
37,729
+17,872
| +90% | +$1,000K |
|
|
AVID
1221
DELISTED
Avid Technology Inc
AVID
| $1.92M | ﹤0.01% |
82,359
+12,704
| +18% | +$331K |
|
1222
Ginkgo Bioworks
DNA
$488M
| $1.91M | ﹤0.01% |
+15,310
| New | +$1.82M |
|
|
PLYA
1223
DELISTED
Playa Hotels & Resorts
PLYA
| $1.9M | ﹤0.01% |
326,911
+310,501
| +1,892% | +$2.06M |
|
1224
Alto Ingredients
ALTO
$326M
| $1.9M | ﹤0.01% |
521,742
+47,439
| +10% | +$200K |
|
1225
John Wiley & Sons Class A
WLY
$2.63B
| $1.9M | ﹤0.01% |
50,539
-33,595
| -40% | -$1.6M |
|
Similar funds
AQR Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, AQR Capital Management held 2,407 positions worth $41B, down 7.3% from $44.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q3 2022 filing shows 233 new, 1,091 increased, 839 reduced and 232 closed positions. Its largest new stake was Applovin: 596,316 shares worth $11.6M. The largest sale was Allstate, an estimated $109M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q3 2022 buy was Applovin: 596,316 shares worth $11.6M.
- AQR Capital Management added most to Tesla in Q3 2022, an estimated $119M increase.
- AQR Capital Management's biggest Q3 2022 reduction was Allstate, cutting an estimated $109M.
- AQR Capital Management fully exited Baidu in Q3 2022, selling an estimated $31.3M.
- AQR Capital Management's ten largest holdings make up 14% of its $41B portfolio in Q3 2022.
- AQR Capital Management opened 233 new positions and closed 232 in Q3 2022.
- AQR Capital Management's portfolio value fell 7.3% quarter-over-quarter to $41B.
Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.